Please provide your email address to receive an email when new articles are posted on . Phase 3 results show a statistical improvement in molluscum contagiosum during TO-208 treatment vs. placebo.

Credit: Pelthos Therapeutics. Equal amounts of gel from Tube A and Tube B should be dispensed and mixed on the dosing guide. The treatment can be applied at home by the patient or caregiver. Zelsuvmi ...

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that the U.S. Food and Drug Administration (FDA) has approved ZELSUVMI™ (berdazimer topical gel, 10.3%) ...

On January 5, the Food and Drug Administration (FDA) approved berdazimer gel 10.3% for the treatment of molluscum contagiosum (MC) in adults and children aged 1 year or older. Only 4.1% of patients on ...

The FDA approved the first at-home topical therapy for molluscum contagiosum, a highly contagious viral skin infection that primarily affects children. The approval of berdazimer gel 10.3% (Zelsuvmi) ...

"It's 3 a.m. and I'm in the hospital because I bought a wig off of Amazon," writer Kayla Knight says in a video posted to her TikTok account. In it, Knight is seen in a hospital gown and bonnet with ...

Please provide your email address to receive an email when new articles are posted on . MIAMI BEACH, Fla. — The recent FDA approvals of two treatments for molluscum contagiosum may represent a shift ...

Molluscum contagiosum (MC), a viral skin infection caused by the poxvirus, often presents challenges in treatment due to limited therapeutic options. However, a potential breakthrough has emerged with ...

Molluscum contagiosum is a prevalent viral skin infection, particularly in children, that presents as small, firm, flesh-coloured papules. Although the condition is typically self‐limiting, its ...

Molluscum contagiosum is a widespread viral skin infection that commonly affects children. However, adults, particularly those with weakened immune systems, may also develop this condition. Molluscum ...

Pelthos is set to launch ZELSUVMI™, the first and only home-administered prescription treatment for Molluscum contagiosum, addressing a significant unmet need. The successful merger has raised $50.1 ...